Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicago Inc MDCGF

Healthcare Biotechnology


GREY:MDCGF - Post by User

Medicago Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Post by Jentaion Oct 21, 2010 12:40pm
376 Views
Post# 17593582

Phase2...positive boost...to come

Phase2...positive boost...to comeI must admit, I am pleased with the news concerning Phillip Morris. If they had decided to exercise their warrants, our “favourite” stock would have been really diluted.  Positive news...and the stock is going down...a common occurrence with this one.  IR has been deluged with phone calls so far today.  From my level 2, someone with an account at the BMO has been buying steadily this morning.  I suspect the upcoming confirmation of the beginning of Phase 2 should give us a positive boost.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities